Company profile: Biosurfit
1.1 - Company Overview
Company description
- Provider of point-of-care and at-home diagnostic solutions, including spinit, a quantitative blood analysis platform for immunoassay, haematology and clinical chemistry; at-home lab testing with home sample collection; mylab.care clinical analyses, exams, consultations and nutrition advice; Pharmacare e-commerce for non-prescription drugs, supplements, self-tests and other health products; and contract design and manufacturing based on proprietary technology.
Products and services
- Spinit: A point-of-care diagnostics system that delivers fast, precise, affordable quantitative measurement of blood parameters using multiple detection methods targeting immunoassay, haematology, and clinical chemistry
- Contract Development & Manufacturing: A custom-engineered service that architects and fabricates client products using Biosurfit’s proprietary technology, covering end-to-end design and manufacturing for client-specific components and assemblies
- At-Home Lab Testing: An at-home service that delivers blood analysis with convenient at-home sample collection, enabling users to perform clinical analyses without visiting a clinic
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biosurfit
Cordant Health Solutions
HQ: United States
Website
- Description: Provider of drug testing and case-management solutions for health, chronic pain, and criminal justice, including Cordant Sentry for automated patient testing randomization, real-time results, and compliance alerts; urine, oral fluid, hair, and blood drug testing; and behavioral health solutions with laboratory testing, pharmacy services, and adherence monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cordant Health Solutions company profile →
HealthFair
HQ: United States
Website
- Description: Provider of health and wellness services including awareness, education and preventive health tests via mobile health centers to help consumers improve and extend lives through early detection and prevention of disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HealthFair company profile →
Diagnostic Products
HQ: United States
Website
- Description: Provider of in vitro diagnostics, including the IMMULITE(R) series of immunoassay systems, more than 75 immunoassays, and an expanding menu of essential specific allergens and allergy panels that are run just like other immunoassays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diagnostic Products company profile →
Navigenics
HQ: United States
Website
- Description: Provider of personal genomics services using genetic testing to assess individual risk for health conditions, educating and empowering individuals and their physicians with knowledge of genetic predispositions to motivate prevention, enable earlier diagnosis, and support appropriate disease management to lessen disease impact.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Navigenics company profile →
Spinreact
HQ: Spain
Website
- Description: Provider of biotechnology research and development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spinreact company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biosurfit
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biosurfit
2.2 - Growth funds investing in similar companies to Biosurfit
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biosurfit
4.2 - Public trading comparable groups for Biosurfit
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →